The Synergistic Glucose-lowering Effects of Metformin and Bavachinin on Type II Diabetic Rats

The Synergistic Glucose-lowering Effects of Metformin and Bavachinin on Type II Diabetic Rats

Background: Diabetes is one of the most prevalent endocrine disorders in humans, and its first-line medication is metformin. Peroxisome proliferator-activated receptor gamma (PPAR–γ) agonists are the adjuncts to metformin. Bavachinin is a PPAR pan-agonist with fewer side effects than metformin"...

Full description

Bibliographic Details
Main Authors: Sara Khosraviani, Ali Emami, Samaneh Keshavarz Hedayati, Sanaz Keshavarz Shahbaz, Ehsan Aali, Yazdan Naderi
Format: Article
Language:English
Published: Arak University of Medical Sciences 2023-05-01
Series:Iranian Journal of Toxicology
Subjects:
bavachinin
diabetes mellitus type 2
insulin resistance
metabolic syndrome
metformin
Online Access:http://ijt.arakmu.ac.ir/article-1-1169-en.pdf

Similar Items

Similar Items